IDev Technologies, Inc. Announces the Hiring of a New Executive Management Team
HOUSTON, May 3 /PRNewswire/ -- IDev Technologies, Inc., an emerging leader in the development and marketing of minimally invasive stent systems for the treatment of peripheral vascular and non-vascular diseases, today announces the appointment of five key officers to the Executive Team. The Executive Team that joins Thomas M. Tully, Chairman and CEO, are Eric Schlote, Vice President Sales, Tony Anzalone, Vice President Marketing, Tim Placek, Vice President Regulatory, Gert Jansen, Director European Sales, and John Dame, Controller. Eric Schlote joins IDev Technologies, Inc. after serving as Area Director of Sales at Fox Hollow, a Redwood City, California manufacturer of the SilverHawk(R) artherectomy system. Eric brings great insight into the peripheral vascular disease market segment from prior Sales Management experience in the category. Eric holds a B.S. degree from Southwest Missouri State as well as 11 years of category experience. In his new role, Eric will focus on building a Sales Management team and Direct Sales organization for the company. Tony Anzalone was previously employed at Cyberonics Inc., a manufacturer of Class III medical devices for epilepsy and depression, as Senior Director, Marketing. Tony holds an MBA from New York University and brings over 17 years of Sales and Marketing experience to IDev Technologies, Inc. In his new role, Tony will be responsible for the development and implementation of an organizational Marketing Plan and the assembly of a Marketing Department to support commercialization of the new IDEV stent technology. Tim Placek will lead the regulatory submission process for IDev Technologies, Inc. Previously, Tim was Senior Vice President, Regulatory Affairs, Clinical Affairs and Quality Systems at MicroMed Technology Inc. in Houston, Texas. Tim joins IDev Technologies, Inc. with over 12 years of senior management experience in Regulatory Affairs and Quality Control systems. He holds a B.A. in Speech Pathology and Audiology from the University of South Dakota, and an ASEE degree from South Dakota State University as an Electronic Engineer. Gert Jansen will lead Europe as Director, European Sales for IDev Technologies, Inc. Gert was previously Director, European Sales for VelociMed, which was recently acquired by St. Jude Medical. Gert's knowledge of the European marketplace is well established with a successful track record in two other start-up ventures. Gert holds a B.S. degree in Marketing (NIMA A/B) and brings over 20 years of management experience in the field of medical devices. John Dame is a CPA and joins IDev Technologies, Inc. as Controller. John was previously at United Plastics Group, Chicago, Illinois, as a Division Controller in Springfield, Massachusetts and offers over 20 years of management experience in the discipline of Accounting. John holds a B.S.B.A. from Western New England College and also manages the Human Resources function for the company. "In total, IDev Technologies, Inc. has acquired over 80 years of management experience to lead the organization to future growth," stated Thomas M. Tully, Chairman and CEO. "IDev Technologies, Inc. will continue to focus on acquiring seasoned leadership throughout the organization to drive the successful commercialization of our patented, innovative stent technology." About IDev Technologies, Inc. IDev Technologies, Inc. ("IDEV") is an Innovator and Developer of next generation minimally invasive medical devices for the treatment of peripheral vascular disease (PVD). PVD is currently treated by interventional radiologists, vascular surgeons, and cardiologists. The Company has recently received a CE Mark approval for use of the stent in peripheral vascular and non-vascular applications and is preparing to launch the product in Europe shortly. The IDev Technologies, Inc. stent is a unique device that is a self- expandable nitinol stent with significant radial force that is resistant to kinking, crushing and fracture potential. Additionally, the unique delivery system allows for precise placement and repositionability prior to deployment. These features represent a significant advance over existing stent technologies for peripheral vascular applications.
SOURCE IDev Technologies, Inc.
More by this Source
IDEV gibt Ergebnisse von Studie zur Revaskularisation mit Supera an echten Patienten (RESTORE) bekannt - Studie demonstriert positive klinische Ergebnisse bei schwerkranken Patienten mit langen Läsionen
Feb 01, 2013, 09:16 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.